Recently Featured

Sanofi sells Medley generics unit to EMS for over $500 million

March 29, 2026
Sanofi has finalized an agreement to divest its Medley generics unit in Brazil to EMS, a prominent local pharmaceutical company. The transaction, reported to exceed $500 million, underscores the strategic shift within Sanofi’s portfolio as it refocuses on core therapeutic areas and innovative products. This move aligns with broader trends in the pharmaceutical industry where…

US National Security Commission on Emerging Biotechnology Urges Action on China Competition

March 29, 2026
The National Security Commission on Emerging Biotechnology (NSCEB) has raised urgent concerns regarding the competitive position of the United States in the biotechnology sector, particularly in relation to China. Established in 2022, the NSCEB aims to develop strategies to ensure that the U.S. maintains its leadership in this critical industry. Recent discussions have highlighted the…

COVID-19 Test Approval Process for UK Market Now Open

March 29, 2026
The UK government has officially opened the application process for manufacturers and distributors of COVID-19 test devices seeking approval to market their products. This development is crucial as it aims to streamline the entry of reliable testing solutions into the healthcare system, addressing the ongoing demand for effective diagnostics amidst the pandemic. In the context…

Americans Trust Fauci More Than RFK Jr.

March 29, 2026
A recent survey indicates that a significant majority of Americans express greater trust in Dr. Anthony Fauci compared to Robert F. Kennedy Jr. This finding underscores the ongoing divide in public perception of health officials versus controversial figures in the medical community. Dr. Fauci, who led the National Institute of Allergy and Infectious Diseases during…

Ongoing Cases